Stocks · Real Estate · REIT - Healthcare Facilities
Community Healthcare Trust Incorporated CHCT
$13.62 -3.34% Close, Oct 2, 2026 · NYSE · Market cap $389.1M
High qualityInexpensive vs sector
Next earnings report: Oct 27, 2026
Scroll or pinch to zoom, drag to move. Daily prices adjusted for splits. Markers: E = earnings (green beat, red miss), S = split, D = dividend.
Three things to know
- Operating margin widened to 39.1% from 19.7% a year earlier.
- At 20.3× trailing earnings, the shares trade at the lowest P/E of the company's past five years.
- Net debt is 5.9× EBITDA, a high level of leverage.
PromtFinance scores
Each score is a percentile within the Real Estate sector (0–100). Under each score: how the stock ranks in its sector on every component. As of Oct 5, 2026.
How fast revenue, earnings and cash flow are growing.
- Revenue growth (TTM, YoY)Bottom 46%
- FCF growth (TTM, YoY)Top 14%
- Revenue growth, 3-year CAGRTop 40%
- Revenue growth accelerationBottom 49%
Returns on capital, margins, earnings quality and balance-sheet strength.
- Return on invested capitalTop 43%
- Gross marginTop 33%
- Operating marginTop 29%
- Cash conversion (OCF / net income)Top 28%
- Accruals (lower is better)Top 39%
- Net debt / EBITDA (lower is better)Bottom 50%
- Interest coverTop 39%
How cheap the shares are relative to earnings, cash flow and their own history.
- Earnings yieldTop 30%
- Free-cash-flow yieldTop 16%
- EBITDA / enterprise valueTop 15%
- Sales / enterprise valueTop 36%
- P/E vs own 5-year history (lower is better)Top 9%
Strength and persistence of the price trend, including versus the S&P 500.
- 12-month return excluding last monthBottom 40%
- 6-month returnBottom 24%
- 1-year return vs S&P 500Bottom 43%
- Distance from 52-week highBottom 31%
- Trend checklist (0–4)Bottom 22%
Earnings surprises and analyst sentiment (estimate-revision history is being collected).
- Average EPS surprise, last 4 quartersTop 20%
- Consecutive EPS beatsBottom 18%
- Share of analysts rating BuyBottom 45%
- Upside to consensus price targetTop 44%
Low volatility, shallow drawdowns, low market sensitivity and modest leverage.
- Volatility, 60 days (lower is better)Bottom 16%
- Maximum drawdown, 3 yearsBottom 22%
- Beta vs S&P 500 (lower is better)Top 27%
- Net debt / EBITDA (lower is better)Bottom 50%
What changed
Latest four quarters versus the same period a year earlier (growth: versus one quarter earlier).
| Measure | Before | Now | |
|---|---|---|---|
| Revenue growth (YoY) | 5.0% | 5.4% | ↑ |
| Gross margin | 71.1% | 63.2% | ↓ |
| Operating margin | 19.7% | 39.1% | ↑ |
| FCF margin | 30.9% | 47.6% | ↑ |
Fundamental momentum
| Measure | Now (TTM) | Year / quarter before | Sector rank | |
|---|---|---|---|---|
| Revenue growth (TTM, YoY) | 5.4% | 5.0% | ↑ | Bottom 46% |
| Gross margin | 63.2% | 71.1% | ↓ | Top 33% |
| Operating margin | 39.1% | 19.7% | ↑ | Top 29% |
| Net margin | 16.9% | -6.3% | ↑ | — |
| Free-cash-flow margin | 47.6% | 30.9% | ↑ | — |
| Return on invested capital | 4.8% | — | Top 43% | |
| Revenue growth, 3-year CAGR | 7.5% | — | Top 40% |
Quality of earnings and balance sheet
- Cash conversion (OCF / net income)Above 1× means profits are backed by cash.
- 2.84×
- Accruals (net income − OCF) / assetsLower is better; high accruals can signal weaker earnings quality.
- -3.8%
- Stock-based compensation / revenueA cost to shareholders through dilution.
- 4.8%
- Receivables growth vs revenue growthReceivables growing much faster than sales can be a warning.
- -2.4 pp
- Net debt / EBITDABelow 1× is conservative; above 3× is high leverage.
- 5.92×
- Interest cover (operating income / interest)How many times operating profit covers interest.
- 1.6×
Shareholder returns
- Dividend yield (dividends paid, TTM)
- 13.99%
- Net buyback yield (TTM)
- -0.43%
- Shareholder yield
- 13.56%
- Share count change, 1 year
- +0.8%
- Share count change, 3-year CAGR
- +2.5%
Shareholder yield = dividends + net buybacks over the last four quarters, divided by market cap.
Based on the four quarters through Jun 30, 2026 (filed Aug 4, 2026).
Earnings and expectations
Earnings momentum
- Consecutive EPS beats
- 0
- Beats in the last 8 reports
- 1 of 8
- Average EPS surprise, last 4
- +52.9%
- Average 2-day reaction, last 8
- +0.3%
- Positive 20 days after report
- 4 of 8
Analysts
- Consensus price target
- $17.00
- Target vs current price
- +24.8%
- Analysts with a rating
- 16
- Share rating Buy or Strong Buy
- 44%
- Consensus rating
- Hold
How the stock reacted to recent reports
| Report date | EPS surprise | 2 days | 5 days | 20 days | 60 days |
|---|---|---|---|---|---|
| Aug 4, 2026 | -45.5% | -3.0% | -17.2% | -19.4% | — |
| May 5, 2026 | -84.1% | +2.7% | -1.8% | +1.5% | +8.1% |
| Feb 17, 2026 | +400.0% | +2.2% | -7.4% | -6.2% | -3.5% |
| Oct 28, 2025 | -58.8% | -0.2% | +0.8% | +4.0% | +17.2% |
| Jul 29, 2025 | -725.0% | -0.7% | -5.4% | -8.1% | -14.2% |
| Apr 29, 2025 | -55.4% | +1.6% | +6.6% | +2.9% | +2.4% |
| Feb 18, 2025 | -40.4% | -0.5% | -7.4% | -6.0% | -18.3% |
| Oct 29, 2024 | -42.9% | +0.1% | +5.3% | +4.9% | +15.1% |
Returns from the close before each report. Past reactions do not determine future ones.
Earnings history
| Report date | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|
| Aug 4, 2026 | $0.06 | $0.11 | -45.5% | $31.0M |
| May 5, 2026 | $0.07 | $0.44 | -84.1% | $31.3M |
| Feb 17, 2026 | $0.55 | $0.11 | +400.0% | $30.7M |
| Oct 28, 2025 | $0.03 | $0.08 | -58.8% | $30.8M |
| Jul 29, 2025 | -$0.50 | $0.08 | -725.0% | $30.1M |
| Apr 29, 2025 | $0.03 | $0.07 | -55.4% | $29.7M |
| Feb 18, 2025 | $0.04 | $0.07 | -40.4% | $29.0M |
| Oct 29, 2024 | $0.04 | $0.07 | -42.9% | $29.3M |
Valuation in context
| Multiple | Now | 5-year median | 5-year percentile | Sector rank (cheapness) |
|---|---|---|---|---|
| P/E (trailing) | 20.3× | 55.7× | 0th | Top 30% |
| P/E (forward) | 37.8× | — | — | — |
| EV / EBITDA | 10.0× | — | — | Top 15% |
| EV / Sales | 7.64× | — | — | Top 36% |
| Free-cash-flow yield | 15.23% | — | — | Top 16% |
| Earnings yield | 4.93% | — | — | Top 30% |
P/E over the past five years
Range 26.4× – 242.9× since Jun 30, 2021. Each point: price on the filing date divided by trailing-twelve-month EPS known then.
Technical state
Trend checklist
- ✗ Price above 20-day average
- ✗ Price above 50-day average
- ✗ Price above 200-day average
- ✗ 50-day average above 200-day
- ✓ MACD histogram positive
Trend quality
- Days above the 50-day average
- 0
- Days above the 200-day average
- 0
- 50-day average slope (20 days)
- -9.1%
- 200-day average slope (20 days)
- -0.5%
- Distance from 50-day average
- -11.3%
- Distance from 200-day average
- -18.4%
- RSI (14)
- 26.7
- Relative volume
- 1.48×
Risk and drawdowns
- Volatility, 60 days (annualized)
- 36.9%
- Volatility vs own 5-year history
- 92th percentile · High for this stock
- Beta vs S&P 500 (2 years, weekly)
- 0.36
- Correlation with S&P 500
- 0.20
- Current drawdown from 1-year high
- -28.4%
- Maximum drawdown, 3 years
- -55.2%
Largest declines in the past six years
| From peak | To low | Decline | Length | Recovery |
|---|---|---|---|---|
| Apr 27, 2021 | Oct 10, 2025 | -74.5% | 1120 days | Not yet recovered |
| Oct 2, 2020 | Mar 1, 2021 | -14.2% | 101 days | 35 days (Apr 20, 2021) |
Declines of 10% or more from a closing high, measured on daily closes.
Financial statements
- Market cap
- $389.1M
- P/E (TTM)
- 20.3
- EPS, diluted (TTM)
- $0.67
- Revenue (TTM)
- $124.5M
- Dividend yield
- 12.94%
- 52-week range
- $13.23 – $19.17
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Revenue | $90.6M | $97.7M | $112.8M | $115.8M | $121.2M |
| Gross profit | $75.4M | $81.0M | $92.1M | $93.0M | $10.5M |
| Operating income | $32.9M | $33.9M | $25.1M | $20.1M | $20.3M |
| Net income | $22.5M | $22.0M | $7.7M | -$3.2M | $5.1M |
| EPS (diluted) | $0.87 | $0.81 | $0.20 | -$0.23 | $0.08 |
| Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $29.6M | $29.3M | $30.1M | $29.1M | $30.8M | $30.9M | $31.5M | $31.2M |
| Net income | $1.7M | $1.8M | $1.6M | -$12.6M | $1.6M | $14.4M | $2.5M | $2.4M |
| EPS (diluted) | $0.04 | $0.04 | $0.03 | -$0.50 | $0.03 | $0.51 | $0.07 | $0.06 |
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Operating cash flow | $56.3M | $60.3M | $61.4M | $58.9M | $56.4M |
| Capital expenditure | -$7.2M | -$10.4M | -$19.0M | -$24.6M | -$20.5M |
| Free cash flow | $49.1M | $49.9M | $42.4M | $34.2M | $35.9M |
| Dividends paid | -$42.4M | -$44.5M | -$48.1M | -$51.7M | -$53.7M |
| Net share buybacks | $38.4M | $20.5M | $44.2M | $7.5M | -$1.8M |
Cash outflows are shown as negative numbers.
- Cash and short-term investments
- $2.7M
- Total assets
- $1.00B
- Total liabilities
- $589.4M
- Total debt
- $564.5M
- Net debt
- $561.8M
- Shareholders’ equity
- $414.2M
As of Jun 30, 2026 (filed Aug 4, 2026).
Dividends
| Ex-date | Amount | Paid |
|---|---|---|
| Aug 19, 2026 | $0.33 | Aug 31, 2026 |
| May 11, 2026 | $0.48 | May 22, 2026 |
| Feb 23, 2026 | $0.48 | Mar 4, 2026 |
| Nov 7, 2025 | $0.48 | Nov 21, 2025 |
| Aug 8, 2025 | $0.47 | Aug 22, 2025 |
| May 9, 2025 | $0.47 | May 23, 2025 |
| Feb 24, 2025 | $0.47 | Mar 5, 2025 |
| Nov 8, 2024 | $0.47 | Nov 22, 2024 |
Short interest
- Shares sold short
- 935,745
- Days to cover
- 3.45
- Change vs previous report
- -15.2%
FINRA short interest, settlement date Sep 15, 2026.